{"id":"https://openalex.org/W2171374635","doi":"https://doi.org/10.1017/s1461145710001549","title":"The M1/M4 preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia","display_name":"The M1/M4 preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia","publication_year":2011,"publication_date":"2011-01-07","ids":{"openalex":"https://openalex.org/W2171374635","doi":"https://doi.org/10.1017/s1461145710001549","mag":"2171374635","pmid":"https://pubmed.ncbi.nlm.nih.gov/21211109"},"language":"en","primary_location":{"id":"doi:10.1017/s1461145710001549","doi":"https://doi.org/10.1017/s1461145710001549","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145710001549","pdf_url":"https://academic.oup.com/ijnp/article-pdf/14/9/1233/17486938/14-9-1233.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/ijnp/article-pdf/14/9/1233/17486938/14-9-1233.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077166020","display_name":"Segev Barak","orcid":"https://orcid.org/0000-0002-3143-6777","observed_orcids":["https://orcid.org/0000-0002-3143-6777"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]}],"countries":["IL"],"is_corresponding":true,"raw_author_name":"Segev Barak","raw_affiliation_strings":["Department of Psychology, Tel-Aviv University, Tel-Aviv, Israel. sbarak@gallo.ucsf.edu","Department of Psychology, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychology, Tel-Aviv University, Tel-Aviv, Israel. sbarak@gallo.ucsf.edu","institution_ids":["https://openalex.org/I16391192"]},{"raw_affiliation_string":"Department of Psychology, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109862768","display_name":"Ina Weiner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Ina Weiner","raw_affiliation_strings":["Department of Psychology, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychology, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5077166020"],"corresponding_institution_ids":["https://openalex.org/I16391192"],"apc_list":{"value":2042,"currency":"GBP","value_usd":2693},"apc_paid":null,"fwci":2.9507,"has_fulltext":true,"cited_by_count":60,"citation_normalized_percentile":{"value":0.90728549,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"14","issue":"9","first_page":"1233","last_page":"1246"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/xanomeline","display_name":"xanomeline","score":0.9990000128746033},{"id":"https://openalex.org/keywords/latent-inhibition","display_name":"latent inhibition","score":0.8960000276565552},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8169999718666077},{"id":"https://openalex.org/keywords/amphetamine","display_name":"amphetamine","score":0.6759999990463257},{"id":"https://openalex.org/keywords/mk-801","display_name":"MK-801","score":0.8650000095367432},{"id":"https://openalex.org/keywords/scopolamine","display_name":"scopolamine","score":0.9789999723434448},{"id":"https://openalex.org/keywords/nmda-receptor-antagonism","display_name":"NMDA receptor antagonism","score":0.8119999766349792},{"id":"https://openalex.org/keywords/positive-symptoms","display_name":"positive symptoms","score":0.7070000171661377},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cognitive-symptoms","display_name":"cognitive symptoms","score":0.9350000023841858},{"id":"https://openalex.org/keywords/cognitive-enhancement","display_name":"cognitive enhancement","score":0.531000018119812},{"id":"https://openalex.org/keywords/cholinergic-side-effects","display_name":"cholinergic side effects","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.7677658796310425},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6387168765068054},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6159371137619019},{"id":"https://openalex.org/C67758918","wikidata":"https://www.wikidata.org/wiki/Q2744408","display_name":"Latent inhibition","level":4,"score":0.5151354074478149},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5101481080055237},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.47200843691825867},{"id":"https://openalex.org/C2778576352","wikidata":"https://www.wikidata.org/wiki/Q337188","display_name":"Scopolamine","level":2,"score":0.4692378342151642},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.4560742974281311},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3576946258544922},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3123652935028076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22620373964309692},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.19963055849075317},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1451573669910431},{"id":"https://openalex.org/C39617858","wikidata":"https://www.wikidata.org/wiki/Q212737","display_name":"Classical conditioning","level":3,"score":0.07912382483482361},{"id":"https://openalex.org/C45262634","wikidata":"https://www.wikidata.org/wiki/Q5159291","display_name":"Conditioning","level":2,"score":0.06105968356132507},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009433","descriptor_name":"Neural Inhibition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009433","descriptor_name":"Neural Inhibition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009433","descriptor_name":"Neural Inhibition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D012601","descriptor_name":"Scopolamine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D012601","descriptor_name":"Scopolamine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D012601","descriptor_name":"Scopolamine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D013618","descriptor_name":"Tachyphylaxis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013618","descriptor_name":"Tachyphylaxis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013618","descriptor_name":"Tachyphylaxis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013830","descriptor_name":"Thiadiazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013830","descriptor_name":"Thiadiazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013830","descriptor_name":"Thiadiazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013830","descriptor_name":"Thiadiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013830","descriptor_name":"Thiadiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013830","descriptor_name":"Thiadiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016291","descriptor_name":"Dizocilpine Maleate","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D016291","descriptor_name":"Dizocilpine Maleate","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D016291","descriptor_name":"Dizocilpine Maleate","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018377","descriptor_name":"Neurotransmitter Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D018377","descriptor_name":"Neurotransmitter Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D018377","descriptor_name":"Neurotransmitter Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018721","descriptor_name":"Muscarinic Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018721","descriptor_name":"Muscarinic Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018721","descriptor_name":"Muscarinic Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018721","descriptor_name":"Muscarinic Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018721","descriptor_name":"Muscarinic Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018721","descriptor_name":"Muscarinic Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D043588","descriptor_name":"Receptor, Muscarinic M4","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D043588","descriptor_name":"Receptor, Muscarinic M4","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D043588","descriptor_name":"Receptor, Muscarinic M4","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D043643","descriptor_name":"Receptor, Muscarinic M1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D043643","descriptor_name":"Receptor, Muscarinic M1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D043643","descriptor_name":"Receptor, Muscarinic M1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1017/s1461145710001549","doi":"https://doi.org/10.1017/s1461145710001549","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145710001549","pdf_url":"https://academic.oup.com/ijnp/article-pdf/14/9/1233/17486938/14-9-1233.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmid:21211109","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21211109","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of neuropsychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1017/s1461145710001549","doi":"https://doi.org/10.1017/s1461145710001549","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145710001549","pdf_url":"https://academic.oup.com/ijnp/article-pdf/14/9/1233/17486938/14-9-1233.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/1","score":0.6899999976158142,"display_name":"No poverty"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320322252","display_name":"Israel Science Foundation","ror":"https://ror.org/04sazxf24"},{"id":"https://openalex.org/F4320322596","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2171374635.pdf","grobid_xml":"https://content.openalex.org/works/W2171374635.grobid-xml"},"referenced_works_count":102,"referenced_works":["https://openalex.org/W269871572","https://openalex.org/W987063875","https://openalex.org/W1483329522","https://openalex.org/W1494737704","https://openalex.org/W1537623475","https://openalex.org/W1897040888","https://openalex.org/W1914381346","https://openalex.org/W1966014791","https://openalex.org/W1967286229","https://openalex.org/W1968098139","https://openalex.org/W1972001547","https://openalex.org/W1972295386","https://openalex.org/W1972973143","https://openalex.org/W1973494814","https://openalex.org/W1975286611","https://openalex.org/W1975682905","https://openalex.org/W1976834251","https://openalex.org/W1980404680","https://openalex.org/W1982486978","https://openalex.org/W1988836643","https://openalex.org/W1989508454","https://openalex.org/W1991263397","https://openalex.org/W1991634597","https://openalex.org/W1993438014","https://openalex.org/W1994753820","https://openalex.org/W1995277843","https://openalex.org/W1999774383","https://openalex.org/W2000169164","https://openalex.org/W2002430271","https://openalex.org/W2002569378","https://openalex.org/W2006909079","https://openalex.org/W2010069187","https://openalex.org/W2011128492","https://openalex.org/W2012911948","https://openalex.org/W2014260646","https://openalex.org/W2016278859","https://openalex.org/W2017386708","https://openalex.org/W2020140782","https://openalex.org/W2020802809","https://openalex.org/W2021489201","https://openalex.org/W2023806007","https://openalex.org/W2028884770","https://openalex.org/W2029037648","https://openalex.org/W2029280276","https://openalex.org/W2030059527","https://openalex.org/W2031336666","https://openalex.org/W2034020626","https://openalex.org/W2036398723","https://openalex.org/W2039301402","https://openalex.org/W2043922259","https://openalex.org/W2043937142","https://openalex.org/W2044791440","https://openalex.org/W2047984053","https://openalex.org/W2048264021","https://openalex.org/W2050620515","https://openalex.org/W2056466807","https://openalex.org/W2057047547","https://openalex.org/W2061408393","https://openalex.org/W2061434445","https://openalex.org/W2062472783","https://openalex.org/W2063897569","https://openalex.org/W2066610089","https://openalex.org/W2067418199","https://openalex.org/W2068538092","https://openalex.org/W2072203135","https://openalex.org/W2073988872","https://openalex.org/W2076818678","https://openalex.org/W2079587879","https://openalex.org/W2080155490","https://openalex.org/W2081792830","https://openalex.org/W2083922834","https://openalex.org/W2084640262","https://openalex.org/W2086596085","https://openalex.org/W2114705376","https://openalex.org/W2116719688","https://openalex.org/W2126680030","https://openalex.org/W2129645905","https://openalex.org/W2130041319","https://openalex.org/W2132980997","https://openalex.org/W2136729540","https://openalex.org/W2138197233","https://openalex.org/W2139564515","https://openalex.org/W2141303219","https://openalex.org/W2144750899","https://openalex.org/W2150063046","https://openalex.org/W2158056802","https://openalex.org/W2158137297","https://openalex.org/W2159012785","https://openalex.org/W2160695817","https://openalex.org/W2161694508","https://openalex.org/W2162836351","https://openalex.org/W2164973255","https://openalex.org/W2166826909","https://openalex.org/W2170091232","https://openalex.org/W2170461909","https://openalex.org/W2315346240","https://openalex.org/W2418683731","https://openalex.org/W2965471197","https://openalex.org/W3156442294","https://openalex.org/W4294856087","https://openalex.org/W4407038619","https://openalex.org/W6668378880"],"related_works":["https://openalex.org/W2057072761","https://openalex.org/W1964139766","https://openalex.org/W2020774880","https://openalex.org/W2034091951","https://openalex.org/W2027494403","https://openalex.org/W2041550531","https://openalex.org/W2063191820","https://openalex.org/W4235386143","https://openalex.org/W2094311337","https://openalex.org/W2086732785"],"abstract_inverted_index":{"A":[0],"major":[1],"challenge":[2],"in":[3,53,127,218,238,241],"developing":[4],"schizophrenia":[5,219],"pharmacotherapy":[6],"is":[7,61,181],"treating":[8],"the":[9,45,48,62,173,179,208,214],"different":[10],"symptoms":[11,151],"of":[12,47,147,152,163,211,216,247],"this":[13],"disorder,":[14],"typically":[15],"divided":[16],"into":[17],"positive,":[18,248],"negative":[19,249],"and":[20,39,140,176,250],"cognitive":[21,40,202,251],"symptoms.":[22,41,185,252],"M\u2081/M\u2084":[23,49,230],"muscarinic":[24],"acetylcholine":[25],"receptor":[26],"(mAChR)":[27],"agonists":[28],"have":[29],"emerged":[30],"as":[31,70],"a":[32,66,87],"promising":[33],"therapeutic":[34],"target,":[35],"particularly":[36],"for":[37,172,207,245],"positive":[38,150],"Here,":[42],"we":[43],"examined":[44],"activity":[46,148],"mAChR-preferring":[50],"agonist":[51],"xanomeline":[52,156,164,187,217],"four":[54],"pharmacological":[55],"latent":[56],"inhibition":[57],"(LI)":[58],"models.":[59],"LI":[60,82,113,129,142,191],"poorer":[63],"conditioning":[64,96],"to":[65,76,86,111,198,223],"stimulus":[67],"previously":[68],"experienced":[69],"irrelevant":[71],"during":[72],"repeated":[73],"non-reinforced":[74,84],"pre-exposure":[75,85],"that":[77,178,229],"stimulus.":[78],"No-drug":[79],"controls":[80],"displayed":[81],"if":[83],"tone":[88],"was":[89,169,196,220],"followed":[90],"by":[91,193],"weak,":[92],"but":[93],"not":[94],"strong,":[95],"(2":[97],"vs.":[98],"5":[99],"tone-shock":[100],"pairings).":[101],"Amphetamine":[102],"(1":[103],"mg/kg)-":[104,120],"or":[105,121],"scopolamine":[106,122],"(0.15":[107],"mg/kg)-treated":[108,124],"rats":[109,125],"failed":[110],"show":[112],"with":[114,130],"weak":[115],"conditioning,":[116],"whereas":[117],"MK801":[118],"(0.05":[119],"(1.5":[123],"persisted":[126],"displaying":[128],"strong":[131],"conditioning.":[132],"Xanomeline":[133],"(5":[134],"mg/kg,":[135],"15":[136],"mg/kg)":[137],"reversed":[138],"amphetamine-":[139],"scopolamine-induced":[141],"disruption,":[143],"effects":[144],"considered":[145],"predictive":[146],"against":[149,183],"schizophrenia.":[153],"In":[154],"addition,":[155],"alleviated":[157,188],"MK801-induced":[158],"abnormally":[159,189],"persistent":[160,190],"LI.":[161],"Activity":[162],"on":[165],"NMDA":[166],"antagonist-induced":[167],"behaviour":[168],"demonstrated":[170],"here":[171],"first":[174],"time":[175],"suggests":[177],"drug":[180,239],"effective":[182],"negative/cognitive":[184],"Finally,":[186],"induced":[192],"scopolamine,":[194],"which":[195],"suggested":[197],"model":[199],"antipsychotic":[200],"drug-resistant":[201],"impairments,":[203],"providing":[204],"further":[205],"evidence":[206],"cognition-enhancing":[209],"capacity":[210],"xanomeline.":[212],"Although":[213],"use":[215],"discontinued":[221],"due":[222],"cholinergic-related":[224],"side-effects,":[225],"our":[226],"findings":[227],"suggest":[228],"mAChR":[231],"agonism":[232],"should":[233],"be":[234],"an":[235],"important":[236],"target":[237],"development":[240],"schizophrenia,":[242],"potentially":[243],"beneficial":[244],"treatment":[246]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}